DxS extends EGFR license with Genzyme Genetics
DxS Ltd has expanded its license with Genzyme Genetics, a business unit of Genzyme Corporation, for epidermal growth factor receptor (EGFR) to include the United States and Canada.
Read MoreSearch Results for: lung cancer
Rosetta Genomics Announces Availability of Third MicroRNA-Based Diagnostic Test: miRview(TM) meso
Posted by Clinical Lab Products | Dec 29, 2008 | Cancer, Miscellaneous |
Rosetta Genomics, Ltd. announced the introduction of its third diagnostic test, miRview(TM) meso.
Read MoreNew MicroRNA-Based Diagnostic Test Now Commercially Available
Posted by Clinical Lab Products | Dec 22, 2008 | Cancer, Miscellaneous |
Rosetta Genomics, Ltd has announced the commercial availability of its second diagnostic test, miRview mets. The test is now commercially available through Rosetta Genomics CLIA-certified lab in Philadelphia.
Read MorePatients Face Higher Health Care Costs in US than Other Western Countries
Posted by Clinical Lab Products | Nov 17, 2008 | Cancer, Miscellaneous |
A 2008 survey of chronically ill adults in Western countries found major differences in health care access, safety, and efficiency, with US patients at high risk of forgoing care because of costs.
Read MoreBiosystems Raises $4.6 Million for New Diagnostics in Cancer
Posted by Clinical Lab Products | Oct 29, 2008 | Cancer, Miscellaneous |
Biosystems International has received venture capital amounting to $4.6 million to foster research and development of lung, colon, and breast cancer diagnostics to be marketed in 2010.
Read More